Sudeep Pharma IPO

Sudeep Pharma IPO

Sudeep Pharma is a technology-led manufacturer of **excipients** and **specialty mineral ingredients** used globally in pharmaceutical, food, and nutrition industries. The company utilizes in-house technologies such as encapsulation, spray drying, and liposomal preparations to produce high-value mineral-based ingredients (calcium, iron, zinc, etc.). Sudeep Pharma is one of the largest producers of food-grade iron phosphate globally and is one of the few companies with a USFDA-approved facility for manufacturing mineral-based ingredients. It serves over 1,100 customers worldwide, including major names like **Pfizer, Merck, Danone, Intas, and Mankind**.

Issue Price
593
Current GMP
₹121 (20.40%)
Overall Subscription
93.71x
Issue Size
₹895.00 Cr
Advertisement

Live Subscription by Application

CategoryApplications OfferedApplications ReceivedSubscription
QIB30,18,5532,5290.00x
FII
-93-
DFI
-54-
MF
-24-
Other
-2,358-
NII6,4682,82,12543.62x
bNII
4,3121,17,65827.29x
Corporate
-852-
Individual
-1,10,892-
Other
-5,914-
sNII
2,1561,64,46776.28x
Corporate
-315-
Individual
-1,56,557-
Other
-7,595-
Retail2,11,29827,23,40412.89x
Cut-off price
-22,36,468-
Fixed price
-4,86,936-
Total32,36,31930,08,0580.93x

Live Subscription by Shares

CategoryShares OfferedShares AppliedSubscription
QIB30.19 L64.32 Cr213.08x
FII
-18.92 Cr-
DFI
-25.77 Cr-
MF
-2.86 Cr-
Other
-16.76 Cr-
NII22.64 L26.42 Cr116.72x
bNII
15.09 L20.36 Cr134.91x
Corporate
-15.44 L-
Individual
-19.19 Cr-
Other
-1.02 Cr-
sNII
7.55 L6.06 Cr80.33x
Corporate
-1.23 L-
Individual
-5.78 Cr-
Other
-27.39 L-
Retail52.82 L8.27 Cr15.65x
Cut-off price
-6.80 Cr-
Fixed price
-1.47 Cr-
Total1.06 Cr99.01 Cr93.72x

Subscription Summary

QIB
Shares Applied:213.08x
Applications Offered:0.00x
NII
Shares Applied:116.72x
Applications Offered:43.62x
Retail
Shares Applied:15.65x
Applications Offered:12.89x

Quick Stats

Total Categories3
IPO TypeMainboard
StatusAllotment Out

Get IPOwiz App

Track IPOs on the go with our mobile app

Download Now

Join us on Telegram for instant IPO updates!

Join Now

Data Last Updated

26 Nov 2025, 01:29 pm

Auto-refreshing
Advertisement

Understanding Subscription Categories

QIB

Qualified Institutional Buyers

Includes FII, DFI, Mutual Funds, and other qualified institutions.

NII

Non-Institutional Investors

High net-worth individuals: bNII (₹10L+) and sNII (₹2L-₹10L).

Retail

Retail Individual Investors

Retail investors with applications up to ₹2 lakh per PAN.

Frequently Asked Questions

What is the current subscription status of Sudeep Pharma IPO?
The current overall subscription for Sudeep Pharma IPO is 93.71x. This indicates the total demand relative to the shares offered. Higher subscription typically suggests strong investor interest.
How to check Sudeep Pharma IPO subscription status?
You can check Sudeep Pharma IPO subscription status on IPOwiz, BSE website, NSE website, or your broker's platform. Subscription data is updated regularly during the IPO period from 21 November 2025 to 25 November 2025.
What do subscription numbers mean?
Subscription numbers show how many times the IPO is oversubscribed. For example, 93.71x means the IPO received 93.71x times more applications than shares available. Higher subscription in retail category generally means lower allotment chances.
When does Sudeep Pharma IPO subscription close?
The subscription for Sudeep Pharma IPO closes on 25 November 2025. Applications must be submitted before the closing time on this date. Late applications will not be accepted.
What is the difference between QIB, NII, and Retail subscription?
QIB (Qualified Institutional Buyers) includes mutual funds, FIIs, and other institutions. NII (Non-Institutional Investors) includes high net-worth individuals investing above ₹2 lakh. Retail includes individual investors with applications up to ₹2 lakh. Each category has separate subscription quotas.
How does subscription affect allotment chances?
Higher subscription in your category means lower allotment chances. For example, if retail subscription is 93.71x, it means there are 93.71x times more applications than shares available, making allotment competitive.
When will Sudeep Pharma IPO allotment be finalized?
The allotment for Sudeep Pharma IPO will be finalized and announced on 26 November 2025. You can check your allotment status on the registrar's website, BSE, NSE, or your demat account after this date.
What happens after subscription closes?
After subscription closes on 25 November 2025, the company and registrar process all applications. Allotment is finalized by 26 November 2025, and shares are credited to successful applicants' demat accounts before the listing date on 28 November 2025.
Can I apply after subscription closes?
No, you cannot apply after the subscription closes on 25 November 2025. All IPO applications must be submitted during the subscription period from 21 November 2025 to 25 November 2025. Late applications are automatically rejected.
What is the issue size and lot size for Sudeep Pharma IPO?
The issue size for Sudeep Pharma IPO is ₹895.00 Cr, and the lot size is 25 shares. The price range is ₹563.0 - ₹593.0. You must apply in multiples of the lot size.